Observational Monocentric Study on Biliary Tract Cancer (BABEL)

NCT05942807 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 560

Last updated 2025-08-26

No results posted yet for this study

Summary

BABEL is an observational, single-center, prospective study about patients affected by biliary tract cancers (BTC) treated at the Medical Oncology Unit of the FPUAG - IRCCS.

Conditions

  • Biliary Tract Cancer

Sponsors & Collaborators

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    lead OTHER

Principal Investigators

  • Lisa Salvatore, MD, PhD · Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-05-15
Primary Completion
2025-05-15
Completion
2026-05-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05942807 on ClinicalTrials.gov